» Articles » PMID: 10366652

Direct Alteration of the P/Q-type Ca2+ Channel Property by Polyglutamine Expansion in Spinocerebellar Ataxia 6

Overview
Journal J Neurosci
Specialty Neurology
Date 1999 Jun 15
PMID 10366652
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Spinocerebellar ataxia 6 (SCA6) is caused by expansion of a polyglutamine stretch, encoded by a CAG trinucleotide repeat, in the human P/Q-type Ca(2+) channel alpha(1A) subunit. Although SCA6 shares common features with other neurodegenerative glutamine repeat disorders, the polyglutamine repeats in SCA6 are exceptionally small, ranging from 21 to 33. Because this size is too small to form insoluble aggregates that have been blamed for the cause of neurodegeneration, SCA6 is the disorder suitable for exploring the pathogenic mechanisms other than aggregate formation, whose universal role has been questioned. To characterize the pathogenic process of SCA6, we studied the effects of polyglutamine expansion on channel properties by analyzing currents flowing through the P/Q-type Ca(2+) channels with an expanded stretch of 24, 30, or 40 polyglutamines, recombinantly expressed in baby hamster kidney cells. Whereas the Ca(2+) channels with </=24 polyglutamines showed normal properties, the Ca(2+) channels with 30 or 40 polyglutamines exhibited an 8 mV hyperpolarizing shift in the voltage dependence of inactivation, which considerably reduces the available channel population at a resting membrane potential. The results suggest that polyglutamine expansion in SCA6 leads to neuronal death and cerebellar atrophy through reduction in Ca(2+) influx into Purkinje cells and other neurons. Besides the widely accepted notion that polyglutamine stretches exert toxic effects by forming aggregates, expanded polyglutamines directly alter functions of the affected gene product.

Citing Articles

Can hyperventilation test and duration of spontaneous nystagmus help differentiate between vascular and inflammatory aetiology of acute unilateral vestibular deficit?.

Califano L, Locatelli G, Melillo M Acta Otorhinolaryngol Ital. 2023; 42(6):560-568.

PMID: 36654523 PMC: 9853109. DOI: 10.14639/0392-100X-N1975.


Cell type-specific biotin labeling in vivo resolves regional neuronal and astrocyte proteomic differences in mouse brain.

Rayaprolu S, Bitarafan S, Santiago J, Betarbet R, Sunna S, Cheng L Nat Commun. 2022; 13(1):2927.

PMID: 35614064 PMC: 9132937. DOI: 10.1038/s41467-022-30623-x.


Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies.

McIntosh C, Li D, Wilton S, Aung-Htut M Biomedicines. 2021; 9(11).

PMID: 34829728 PMC: 8615177. DOI: 10.3390/biomedicines9111499.


Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias.

Hommersom M, Buijsen R, van Roon-Mom W, van de Warrenburg B, van Bokhoven H Stem Cell Rev Rep. 2021; 18(2):441-456.

PMID: 34031815 PMC: 8930896. DOI: 10.1007/s12015-021-10184-0.


Clenbuterol-sensitive delayed outward potassium currents in a cell model of spinal and bulbar muscular atrophy.

Martinez-Rojas V, Arosio D, Pennuto M, Musio C Pflugers Arch. 2021; 473(8):1213-1227.

PMID: 34021780 DOI: 10.1007/s00424-021-02559-6.